Home/Filings/4/0001104659-21-022252
4//SEC Filing

CELLI FRANK E. 4

Accession 0001104659-21-022252

CIK 0001590383other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 7:24 PM ET

Size

7.6 KB

Accession

0001104659-21-022252

Insider Transaction Report

Form 4
Period: 2021-02-10
CELLI FRANK E.
DirectorChairman and CEO
Transactions
  • Sale

    Common Stock, par value $0.0001

    2021-02-10$3.10/sh330,000$1,023,693595,484 total(indirect: By Trust)
Transactions
  • Sale

    Common Stock, par value $0.0001

    2021-02-10$3.10/sh330,000$1,023,693595,484 total(indirect: By Trust)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $3.08 to $3.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Does not include 1,467,777 shares of common stock held by Frank E. Celli, individually.
  • [F3]The securities reported above were not sold by the reporting person but by a family trust of which the reporting person's wife is the sole trustee and of which Frank E. Celli is not a beneficiary. Frank E. Celli disavows voting and dispositive control over the securities held by such trust. The Trust sold the shares for tax and estate planning purposes.

Issuer

BIOHITECH GLOBAL, INC.

CIK 0001590383

Entity typeother

Related Parties

1
  • filerCIK 0001658037

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 7:24 PM ET
Size
7.6 KB